Abstract: The phenomenon of pain, belonging to the burdensome changes occurring in our body, leads to disturbances in normal functioning. An appropriately selected therapy, depending on the severity and symptoms, can lead to its relief. BPC-157 peptide therapy is a modern therapy whose analgesic effect has been proven during conducted studies.
Keywords: pain; BPC-157 therapy; acute pain; chronic pain; phantom pain; spinal pain; thalamic pain; analgesic drugs
List of abbreviations: BPC- body protection compound; CNS- Central Nervous System
What is pain?
The phenomenon of pain is characterized as an unpleasant sensation, both sensory and emotional, and is associated with actual or potential bodily damage. Pain arises as a result of irritation of pain receptors (nociceptors) or as a result of lowering the excitability threshold of these receptors, i.e. so-called receptor pain, as well as in the case of damage to structures of the nervous system, or without accompanying tissue damage. The conduction and formation of pain occurs during the conduction of peripheral nerves such as C fibers and A-delta fibers. The process of pain formation encompasses such stages as: transduction, conduction, modulation, and perception.
The Function of Pain
The primary function of pain is considered to be its warning-protective function. The warning function informs us of impending tissue damage, which leads to a behavioral and reflex response of the body allowing for the limitation of the effects resulting from possible damage. Tissue damage causes the initiation of pain in the peripheral and central nervous system. Additionally, the protective function of pain is attributed to minimizing the possibility of further damage by limiting activity.
Pathomechanism of Pain
Acute Pain
Acute pain serves primarily a protective function, informing the body of actual tissue damage. The body reacts to this type of pain with a strong stress response, e.g. an increase in blood pressure. Acute pain belongs to an unpleasant type of pain with a high scale of intensity and strength.
Chronic Pain
Chronic pain concerns pain processes that accompany a person over a longer period of time. It is sometimes considered a disease that requires specialized therapy. Patients present with symptoms associated with physiological, psychological, and social disorders.
Chronic Receptor Pain
This type of pain occurs in the course of accompanying degenerative joint disease, spinal pain, osteoporosis, or fibromyalgia.
Chronic Neuropathic Pain
Chronically occurring neuropathic pain is caused by damage to the nervous system, spinal cord, or peripheral nerves. Injuries that may cause the occurrence of this type of pain include, among others, ischemia, damage to nerve structures, or radiation.
Phantom Pain
Phantom pain is pain occurring after the amputation of a whole or part of a limb. A person after amputation feels the constant presence of the removed limb and pain felt in that place. This pain may additionally relate to pain after tooth extraction.
Complex Regional Pain Syndromes
Complex Regional Pain Syndrome Type I (Reflex Sympathetic Dystrophy)
Type I pain syndromes are characterized by a local pain syndrome appearing after an initiating injury, not dependent on the innervation area of a single peripheral nerve, and its intensity is disproportionate to the injury. The pain is accompanied by, among others, swelling or sweating at the site of the pain.
Complex Regional Pain Syndrome Type II (Causalgia)
Causalgia is characterized by the occurrence of burning pain, allodynia, or hyperalgesia usually in the area of the hand or foot, after partial damage to a nerve or one of its main branches. Symptoms appear immediately after nerve damage, with exceptions where their manifestation may be delayed by even several months. The pain is accompanied by, among others, great sensitivity to temperature and its changes.
Spinal Pain
Pain accompanying, as the name suggests, during damage to the spinal cord. Pain occurs in this case with varying intensity, however it does not follow a mild course. Patients feel strong or very strong pain within the spinal cord.
Thalamic Pain
Thalamic pain concerns damage to the brain stem and higher levels of the CNS. In this case, central pain of varying intensity occurs, characterized by headaches.
Classification of Analgesic Drugs
Depending on the action profile and ailments, analgesic drugs can be divided into: Non-opioid analgesics (paracetamol, metamizole), weak opioids (tramadol, codeine), and strong opioids (morphine, fentanyl).
BPC-157 peptide therapy is classified among analgesic therapies. It is not classified into any group due to its innovative nature, however it demonstrates very strong analgesic and anti-inflammatory action.
Mechanism of Action of Analgesic Drugs
Depending on the drug group and pain ailments, their mechanism of action will differ from one another. Drugs from the non-opioid group (NSAIDs) act on inflammation by irritating pain receptors, inhibiting the production of cyclooxygenase necessary for the synthesis of prostaglandins as molecules found in all tissues and body fluids. Opioids, in turn, act on opioid receptors to a lesser and greater degree, depending on whether they are weak or strongly acting opioids. Their mechanism of action is based on the attachment of the drug molecule to opioid receptors, which leads to hyperpolarization, which leads to a reduction in the excitability of nerve cells of the receptor, and consequently relieves pain.
Analgesic BPC-157 Therapy
According to conducted studies concerning the interaction between a dopaminergic drug and an opioid, BPC-157 demonstrates anti-receptor activity. Through the action of the peptide, antagonization of pain occurs. Additionally, the analgesic effect of BPC-157 was noted at a very small dose and in a short time. The action of BPC-157 is based on activity through the central dopaminergic system. The above studies demonstrate that BPC-157 peptide is an innovative method of treating pain of varying intensity and pain of various classifications.
Summary
Pain is a symptom that accompanies us in everyday life. Its occurrence reduces our well-being, both physical and psychological, which is why appropriate therapy allowing for its relief is so important. Both therapy with already known drugs and therapy with BPC-157 peptide brings the expected results. Additionally, the use of BPC-157 peptide allows for the elimination of pain of varying intensity, using a small dose that brings the expected therapeutic effect without causing addiction and acting in a safe manner.
Bibliography
1.Sikiric.P, Hahm.K, Blagaic.A, Tvrdeic.A, Pavlov.K, Andrea Petrovic.A, Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. 2016, 14, 857-865; DOI:10.2174/1570159X13666160502153 022
2.Żylicz.Z, Krajnik.M, Jak powstaje ból? Neurofizjologia bólu. 2003, 2, 1, 49–56.






Therapeutic effect of the BPC-157 peptide in the treatment of addiction effects.
BPC-157 Peptide Therapy for the Support of Sports Injuries in Athletes and Physically Active Individuals